rs80359351

badMag 9.0

This is a frameshift variant variant in the BRCA2 gene.

Key Literature Trait Associations

Breast and Ovarian Cancer Risk

rs80359351 (BRCA2 6174delT) is a pathogenic frameshift variant and one of the three Ashkenazi Jewish BRCA founder mutations (~1% carrier frequency in Ashkenazi Jewish individuals). Carriers face a cumulative breast cancer risk of approximately 39% by age 70, which, while lower than other BRCA2 pathogenic variants (~61%), remains substantially elevated above the population baseline. Ovarian/fallopian tube cancer risk is estimated at ~16–21% lifetime penetrance. A landmark 1997 NEJM population-based study in 5,318 Jewish subjects estimated 56% breast cancer risk and 16% ovarian cancer risk by age 70 across BRCA1/2 founder mutations combined. ClinVar lists this variant as pathogenic across all 12 independent submissions.

Allele DELACAA
OR
p 3.0e-3
N 967
Preliminary work
Ashkenazi Jewish
Allele DELACAA
OR
p
N 5,318
Preliminary work
Ashkenazi Jewish
Satagopan JM et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research (2002)
Allele DELACAA
OR
p
N 3,816
Preliminary work
Ashkenazi Jewish
Allele DELACAA
OR 9.30
p
N 1,255
Preliminary work
Ashkenazi Jewish
Allele DELACAA
OR
p 5.0e-3
N 173
Candidate gene study
Ashkenazi Jewish
Allele DELACAA
OR
p
Candidate gene study
multi-ancestry

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…